ISBT: The Universal Language of Safe Blood Transfusion – Ali AlBahar
Ali AlBahar, Transfusion Medicine Specialist, Hematology and Blood Transfusion Researcher (MSc) at Ministry of Health Saudi Arabia, shared a post on LinkedIn:
”In blood transfusion, it’s not just about matching types… it’s about speaking the same global language.
That language is ISBT.
The ISBT classification system standardizes how we define blood group systems and antigens—ensuring clear communication, accurate testing, and safer transfusions.
Blood Group System – a set of antigens encoded by a single gene or closely linked genes at one genetic locus
Antigen – a specific molecular structure (usually a protein or carbohydrate) on the red cell membrane capable of being recognized by antibodies
Why does this matter?
- Reduces laboratory miscommunication
- Improves compatibility testing accuracy
- Enhances patient safety in every transfusion
Each antigen is rigorously defined and internationally validated before being assigned an ISBT code.
Small details make a big difference in transfusion medicine.”

Stay updated with Hemostasis Today.
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS